单分子实时测序解析MUC1可变串联重复变异提升ADTKD诊断
本研究采用单分子实时测序(SMRT)对300例疑似ADTKD-MUC1个体进行MUC1可变串联重复(VNTR)表征,鉴定出215种独特等位基因和9种移码突变,在143个家系中检出71个(50%)携带MUC1移码突变。SMRT测序优于探针延伸法,能检出探针法漏检的突变,且MUC1fs免疫组化可辅助基因未明病例的诊断。
要点
- SMRT测序可解析MUC1 VNTR全长结构及等位基因变异。
- 在疑似ADTKD-MUC1家系中,SMRT检出50%携带移码突变。
- MUC1fs免疫组化有助于基因未明病例的诊断。
核心结论
- SMRT测序能检出几乎所有VNTR相关移码突变,优于获批的探针延伸法。
- 探针延伸法可识别约90%的受累家系。
- MUC1fs免疫组化在基因未明病例中具有附加诊断价值。
研究设计与样本
- 使用SMRT测序对300例个体(来自143个疑似ADTKD-MUC1家系的279例)进行MUC1 VNTR表征。
- 评估VNTR长度、重复结构及移码突变,并与探针延伸法和MUC1fs免疫组化比较。
主要发现
- 鉴定出215种独特VNTR等位基因,由80种独特重复单元组成,其中46种(58%)为新发现。
- 发现9种不同移码突变,存在于52个突变等位基因上。
- 在143个疑似家系中,71个(50%)检出MUC1移码突变,涉及135例受累个体(48%)。
- SMRT测序在2个既往结果不确定的家系和8个探针法设计无法检出的家系中识别出移码突变。
- SMRT测序成功时,与探针延伸法在家系水平一致率100%,个体水平98%,不一致归因于等位基因脱扣。
关键数值与推荐
- 59dupC为最 prevalent 突变,影响约90%的家系,其余8种突变类型最多出现两次。
临床怎么用
- 对于疑似ADTKD-MUC1病例,SMRT测序可提高移码突变检出率。
- 探针延伸法阴性或结果不确定时,可考虑SMRT测序。
- 基因未明病例可借助MUC1fs免疫组化辅助诊断。
局限性
- 长距离PCR扩增和长读长测序均存在等位基因脱扣,导致个体水平不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Single-molecule real-time sequencing with the PacMUC1 script resolved exact MUC1 variable tandem repeat structure and full allelic variation. In 300 individuals, the protocol identified 215 distinct MUC1 tandem repeat alleles with 80 repeat units and nine frameshift mutation types. Probe extension assay identified 90% of families with frameshift mutations, detection of frameshifted mucin-1 aided genetically unresolved cases. BACKGROUND: ADTKD- MUC1 is caused by frameshift mutations in the MUC1 gene, producing a frameshifted neoprotein (MUC1fs) toxic to kidney cells. The gene's variable number of tandem repeats (VNTR), with approximately 80% guanine/cytosine content, has made it largely inaccessible to standard short-read sequencing, leaving the reference sequence and natural variation poorly defined and complicating mutation detection. METHODS: Using single-molecule real-time (SMRT) sequencing, we characterized MUC1 VNTR in 300 individuals, including 279 from 143 families suspected of having ADTKD- MUC1 , assessing VNTR length, repeat structure, and frameshift mutations. Results were compared with the Clinical Laboratory Improvement Amendments-approved probe-extension assay, detecting the prevalent 59dupC mutation, and with MUC1fs immunohistochemistry, which detects the pathogenic protein independent of the underlying genomic change. RESULTS: We identified 215 unique VNTR alleles composed of 80 distinct repeat units, 46 (58%) of which were novel, and nine distinct frameshift mutations present on 52 mutated alleles. Overall, MUC1 frameshift mutations were identified in 71 of 143 families (50%) with suspected ADTKD- MUC1 , comprising 135 affected individuals (48%). The SMRT assay outperformed the probe-extension assay by identifying frameshift mutations in two families with previously inconclusive results and in eight additional families whose mutations were undetectable by the probe-extension design. When successful, SMRT assay showed 100% concordance with probe-extension assay at the family level and 98% at the individual level, with discordance attributable to allelic dropout inherent to both long-range PCR amplification and long-read sequencing. Analysis of the mutational spectrum confirmed 59dupC as the most prevalent mutation, affecting approximately 90% of families, while the other eight mutation types occurred at most twice. CONCLUSIONS: The SMRT assay outperformed the Clinical Laboratory Improvement Amendments-approved probe-extension assay by detecting essentially all VNTR-associated frameshift mutations. The probe-extension assay identified approximately 90% of affected families. MUC1fs immunohistochemistry added diagnostic value in genetically unresolved cases by detecting the pathogenic protein independent of the underlying mutation.
引用
- Vrbacká A, Přistoupilová A, Kidd KO, et al. Single-Molecule Real-Time Sequencing for MUC1 Variable Number of Tandem Repeat Variation to Improve Autosomal Dominant Tubulointerstitial Kidney Disease Diagnosis. J Am Soc Nephrol. 2026. PMID: 41961547. doi:10.1681/ASN.0000001103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。